http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115058391-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0668 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0665 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate | 2022-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115058391-B |
| titleOfInvention | A method for culturing hypoxic umbilical cord mesenchymal stem cells |
| abstract | The invention relates to the technical field of biomedicine, in particular to a method for culturing hypoxic umbilical cord mesenchymal stem cells. A method for culturing hypoxic umbilical cord mesenchymal stem cells of the present invention, which clarifies the relevant process and quality control standards for hypoxic culture treatment of human umbilical cord mesenchymal stem cells, and the result of hypoxic treatment significantly increases cell survival In the first stage, the level of VEGF secretion in mesenchymal stem cells is significantly increased, and the time for the cells to play a role after entering the body is prolonged, further achieving the effect of improving the therapeutic effect. |
| priorityDate | 2022-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.